Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWQ54
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,763
Award facts
- Contract value 100% obligated
- $5,762.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of XOLAIR 150 mg/ml syringes, with a contract ceiling value of $5,762.72 and an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor vehicle valued through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency and its Medical Supply Chain division. The company's federal contract portfolio demonstrates extensive capabilities in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for XOLAIR, a specialty immunological medication, reflects the company's continued role in fulfilling the federal government's pharmaceutical supply requirements for military medical systems.
Quick answers
Who was awarded contract SPE2DB25FWQ54?
SPE2DB25FWQ54 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FWQ54 worth?
The government has obligated $5,763 on SPE2DB25FWQ54.
Is contract SPE2DB25FWQ54 an order under another contract?
Yes. SPE2DB25FWQ54 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWQ54 competed?
The extent of competition for SPE2DB25FWQ54 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award